Boston Scientific Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2019
Total Assets: $30.57B
Liabilities Breakdown FY2019
Total Liabilities: $16.69B
Asset Breakdown
Total Assets: $30.57B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $217.0M | 0.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $1.58B | 5.2% |
| Property, Plant & Equipment | $2.08B | 6.8% |
| Goodwill | $10.18B | 33.3% |
| Intangible Assets | $7.89B | 25.8% |
| Other Assets | $8.63B | 28.2% |
Liabilities Breakdown
Total Liabilities: $16.69B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $542.0M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.15B | 96.8% |